Compounds > lovastatin
Page last updated: 2024-08-23

lovastatin and Sarcoma, Ewing

lovastatin has been researched along with Sarcoma, Ewing in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boos, J; Eckervogt, V; Sonnemann, J; Truckenbrod, B; van Valen, F; Winkelmann, W1
Dricu, A; Girnita, L; Larsson, O; Nilsson, G; Wang, M; Wejde, J; Xie, Y2
Choi, YH; Jang, JS1
Birrer, MJ; Blagosklonny, MV; Choi, YH; Kim, JS; Knepper, B; Mushinski, JF; Nguyen, PM; Pirnia, F; Schaefer, O; Schulte, TW; Trepel, JB; Tsokos, M1

Other Studies

5 other study(ies) available for lovastatin and Sarcoma, Ewing

ArticleYear
The bisphosphonate pamidronate is a potent inhibitor of Ewing's sarcoma cell growth in vitro.
    Anti-cancer drugs, 2003, Volume: 14, Issue:9

    Topics: Antineoplastic Agents; Cell Division; Cell Line, Tumor; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Humans; Lovastatin; Pamidronate; Sarcoma, Ewing

2003
Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
    Experimental cell research, 1999, Jan-10, Volume: 246, Issue:1

    Topics: Amino Acid Sequence; Blotting, Western; Cell Division; Cell Nucleus; Cytoplasm; DNA, Neoplasm; Down-Regulation; Gene Expression Regulation; Glucosamine; Glycosylation; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mevalonic Acid; Molecular Sequence Data; Molecular Weight; Oligonucleotides, Antisense; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; RNA-Binding Protein EWS; Sarcoma, Ewing; Time Factors; Transcription Factors; Tumor Cells, Cultured; Tunicamycin

1999
Proteolytic degradation of the retinoblastoma family protein p107: A putative cooperative role of calpain and proteasome.
    International journal of molecular medicine, 1999, Volume: 4, Issue:5

    Topics: Acetylcysteine; Antineoplastic Agents; Blotting, Western; Calcium-Binding Proteins; Calpain; CDC2-CDC28 Kinases; Cell Cycle; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Cysteine Proteinase Inhibitors; Humans; Lovastatin; Male; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Retinoblastoma Protein; Retinoblastoma-Like Protein p107; Sarcoma, Ewing; Transfection; Tumor Cells, Cultured; Ubiquitins

1999
Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: therapeutic implications.
    Anti-cancer drug design, 2000, Volume: 15, Issue:1

    Topics: Antineoplastic Agents; Cell Division; Cell Survival; Down-Regulation; Glycosylation; Humans; Lovastatin; Receptor, IGF Type 1; Sarcoma, Ewing; Tumor Cells, Cultured; Tunicamycin

2000
Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint.
    Oncogene, 2000, Dec-07, Volume: 19, Issue:52

    Topics: Apoptosis; Biomarkers; Cell Cycle Proteins; Cell Size; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; DNA; Down-Regulation; Ectoderm; Flow Cytometry; G1 Phase; Genes, cdc; Humans; Immunohistochemistry; Lovastatin; Microscopy, Electron, Scanning; Microtubule-Associated Proteins; Mitotic Index; Neurons; Retinoblastoma Protein; Sarcoma, Ewing; Tumor Cells, Cultured; Tumor Suppressor Proteins

2000